Why ProShares Ultra Health Care (RXL) Stock Is Up +23% in the Last 30 Days
Key Takeaways
- RXL has climbed roughly 23% over the past 30 days, advancing from about $59 to approximately $73.
- The fund's 2x daily leverage means it moves at roughly twice the pace of the underlying U.S. health care sector index.
- The primary catalyst was a broad health care rally after Democrats won control of both chambers of Congress in the November midterms.
- A rotation into defensive, record-setting health care names added momentum as technology and AI shares cooled.
- Over the last quarter the fund is up about 24%, with nearly all of the gain concentrated in the recent rally.
- As a leveraged product, RXL carries elevated volatility and compounding risks and is designed for short-term tactical use.
- For more detail, explore RXL's Price Targets, Earnings, and Forecast on dedicated pages.
- Explore Trending AI Robots to see top-performing AI trading bots.
ProShares Ultra Health Care (RXL) Company Overview and Market Position
ProShares Ultra Health Care (RXL) is an exchange-traded fund rather than a single operating company. Launched in January 2007 by ProShares, it seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select Sector Index, a benchmark of large U.S. health care companies. The fund typically uses derivatives such as swaps to deliver this leveraged exposure.
RXL holds roughly 59 positions spanning pharmaceuticals, biotechnology, medical devices, health care providers, and managed care. Its largest weightings include Eli Lilly (LLY), Johnson & Johnson (JNJ), AbbVie, Merck, and UnitedHealth Group (UNH). Investors follow RXL as a leveraged, single-ticker vehicle for expressing a short-term view on the health care sector, though the 0.95% expense ratio and daily reset make it a tactical rather than buy-and-hold tool.
ProShares Ultra Health Care (RXL) Stock Price Performance: Last 30 Days vs. Quarter
Over the last 30 days, RXL advanced from a closing price of roughly $59.33 to about $73.05, a gain of approximately 23%. Because the fund targets 2x daily exposure, this move reflects a sharp upswing in the underlying health care index, which rose roughly 10% over the same window, rather than a single-stock event.
The last quarter tells a similar story with a different texture. Measured from mid-August, RXL traded near $58.96 and now sits around $73.05, up about 24%. Nearly all of that advance occurred after mid-October; the fund spent much of August through early October oscillating in a range, dipping to the mid-$56 level in early October before the rally took hold.
What Drove RXL Stock Price in the Last 30 Days
The dominant catalyst was the U.S. midterm election. After Democrats secured control of both the Senate and the House, health care stocks rallied broadly on expectations of more favorable policy: protection of Medicaid and Affordable Care Act programs, potential restoration of enhanced ACA subsidies, and possible delays to Medicaid-related cuts in the One Big Beautiful Bill Act. Hospital operators, Medicaid-focused insurers, and pharmaceutical companies all advanced, lifting the sector index RXL tracks.
That policy-driven move was reinforced by a defensive rotation. As concerns grew around the artificial-intelligence boom and technology shares corrected, investors rotated into health care, helping push the sector index to record highs. Because RXL provides 2x daily leverage, these underlying sector gains translated into a roughly 23% rise in the fund itself.
What Drove RXL Stock Performance Over the Last Quarter
The quarterly picture is defined less by steady appreciation than by a sharp, catalyst-driven repricing in late October and November. From mid-August through mid-October, RXL traded in a broad range, pressured by uncertainty over health care policy, drug-pricing rhetoric, and mixed sector sentiment. The election result in early November removed a major overhang for Medicaid- and ACA-exposed names and triggered a powerful rally.
Broader themes also played a role: a rotation from richly valued technology and AI names into defensive, cash-generative health care businesses, and a reassessment of the sector as a "second growth" trade amid an aging population and renewed innovation in specialty pharmaceuticals. For a leveraged fund, these compounding daily gains produced an outsized total move relative to the underlying index.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of AI-powered trading bots drawn from a broader lineup of hundreds of bots that collectively trade thousands of tickers. Only the top-performing and most relevant bots appear in this section, giving traders a focused view of strategies that are currently attracting attention. These bots differ in approach, holding timeframe, and performance metrics, so users can compare how each model behaves across different market conditions. The page is designed to help traders monitor which automated strategies are trending, offering a practical starting point for evaluating data-driven trading tools. To see the latest featured strategies, visit Trending AI Robots.
RXL Stock Forecast Drivers: What Investors Should Watch Next
Investors should monitor several factors that could shape RXL's direction. First is policy follow-through: the incoming Congress will not be seated until January, and legislative outcomes on ACA subsidies and Medicaid cuts remain uncertain, with presidential veto power a key variable. Second, the broader rotation between growth and defensive sectors will influence whether health care's momentum persists. Third, earnings and guidance from the sector's largest constituents, including major pharmaceutical, biotech, and managed-care names, will set the tone for the underlying index. Finally, as a 2x leveraged fund, RXL's daily reset means returns over periods longer than one day can diverge significantly from twice the index, especially in volatile or choppy markets.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
RXL's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for RXL turned positive on October 09, 2026. Looking at past instances where RXL's MACD turned positive, the stock continued to rise in 41 of 46 cases over the following month. The odds of a continued upward trend are 89%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on RXL as a result. In 78 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
RXL moved above its 50-day moving average on October 09, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for RXL crossed bullishly above the 50-day moving average on October 15, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 87%.
Following a +0.59% 3-day Advance, the price is estimated to grow further. Considering data from situations where RXL advanced for three days, in 276 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The Aroon Indicator entered an Uptrend today. In 227 of 255 cases where RXL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.
Bearish Trend Analysis
The 10-day RSI Indicator for RXL moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 22 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
RXL broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement